Citius Pharmaceuticals (CTXR) Operating Leases (2019 - 2026)
Citius Pharmaceuticals' Operating Leases came in at $590,787 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 23.0% from $766,957 a year earlier and down 7.2% from the prior quarter.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals' Operating Leases was $724,925.
- Operating Leases carries a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
- Going back by fiscal year, Operating Leases was $21,318 in FY2024 (-91.9%), $262,865 in FY2023 (-45.4%), $481,245 in FY2022 (-29.0%) and $678,234 in FY2021 (-20.7%).
- The fiscal Q3 2026 figure represents the lowest quarterly Operating Leases since fiscal Q4 2024.
- Year-over-year, Operating Leases increased in two of the last five quarters, with growth averaging 223.3%.
- The fastest year-over-year change in Operating Leases over five years came in fiscal Q3 2025 (growth of 808.4%), and the weakest in fiscal Q4 2024 (a decline of 91.9%).
- Business Quant data shows CTXR's Operating Leases at $636,667 (Q2 2026), $681,640 (Q1 2026) and $724,925 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Citius Pharmaceuticals | 10.37 Mn | -23.20 Mn | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 590,787.00 |
| Mar 31, 2026 | 636,667.00 |
| Dec 31, 2025 | 681,640.00 |
| Sep 30, 2025 | 724,925.00 |
| Jun 30, 2025 | 766,957.00 |
| Mar 31, 2025 | 786,697.00 |
| Sep 30, 2024 | 21,318.00 |
| Jun 30, 2024 | 84,430.00 |
| Mar 31, 2024 | 145,098.00 |
| Dec 31, 2023 | 204,569.00 |
| Sep 30, 2023 | 262,865.00 |
| Jun 30, 2023 | 320,011.00 |
| Mar 31, 2023 | 374,831.00 |
| Dec 31, 2022 | 428,568.00 |
| Sep 30, 2022 | 481,245.00 |
| Jun 30, 2022 | 532,883.00 |
| Mar 31, 2022 | 582,302.00 |
| Dec 31, 2021 | 630,745.00 |
| Sep 30, 2021 | 678,234.00 |
| Jun 30, 2021 | 724,785.00 |
API Access
Citius Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();